Critical Prosurvival Roles for C/EBPβ and Insulin-Like Growth Factor I in Macrophage Tumor Cells

REFERENCES

• Akira, S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., and Kishimoto T.. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1897–1906.
   PubMed Web of Science ®Google Scholar
• Alessi, D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., and Hemmings B. A.. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541–6551.
   PubMed Web of Science ®Google Scholar
• Andrews, D. W., Resnicoff M., Flanders A. E., Kenyon L., Curtis M., Merli G., Baserga R., Iliakis G., and Aiken R. D.. 2001. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. J. Clin. Oncol. 19:2189–2200.
   PubMed Web of Science ®Google Scholar
• Baker, J., Liu J. P., Robertson E. J., and Efstratiadis A.. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82.
   PubMed Web of Science ®Google Scholar
• Baserga, R. 1995. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:249–252.
   PubMed Web of Science ®Google Scholar
• Blasi, E., Mathieson B. J., Varesio L., Cleveland J. L., Borchert P. A., and Rapp U. R.. 1985. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature 318:667–670.
   PubMed Web of Science ®Google Scholar
• Blasi, E., Radzioch D., Merletti L., and Varesio L.. 1989. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus. Cancer Biochem. Biophys. 10:303–317.
   PubMedGoogle Scholar
• Blasi, E., Radzioch D., and Varesio L.. 1988. Inhibition of retroviral mRNA expression in the murine macrophage cell line GG2EE by biologic response modifiers. J. Immunol. 141:2153–2157.
   PubMedGoogle Scholar
• Blasi, E., Varesio L., and Wiltrout R. H.. 1988. Tumor formation by a murine macrophage cell line immortalized in vitro by v-raf and v-myc oncogenes. Cancer Immunol. Immunother. 27:109–113.
   PubMedGoogle Scholar
• Bouchard, C., Staller P., and Eilers M.. 1998. Control of cell proliferation by Myc. Trends Cell Biol. 8:202–206.
   PubMed Web of Science ®Google Scholar
• Buck, M., Poli V., Hunter T., and Chojkier M.. 2001. C/EBPβ phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol. Cell 8:807–816.
   PubMed Web of Science ®Google Scholar
• Buck, M., Poli V., van der Geer P., Chojkier M., and Hunter T.. 1999. Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha. Mol. Cell 4:1087–1092.
   PubMed Web of Science ®Google Scholar
• Bundy, L. M., and Sealy L.. 2003. CCAAT/enhancer binding protein beta (C/EBPβ)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22:869–883.
   PubMedGoogle Scholar
• Cheng, L., Du C., Murray D., Tong X., Zhang Y. A., Chen B. P., and Hawley R. G.. 1997. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther. 4:1013–1022.
   PubMedGoogle Scholar
• Cox, G. W., Mathieson B. J., Gandino L., Blasi E., Radzioch D., and Varesio L.. 1989. Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J. Natl. Cancer Inst. 81:1492–1496.
   PubMedGoogle Scholar
• Descombes, P., Chojkier M., Lichtsteiner S., Falvey E., and Schibler U.. 1990. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev. 4:1541–1551.
   PubMed Web of Science ®Google Scholar
• Descombes, P., and Schibler U.. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569–579.
   PubMed Web of Science ®Google Scholar
• Dveksler, G. S., Basile A. A., and Dieffenbach C. W.. 1992. Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. PCR Methods Appl. 1:283–285.
   PubMedGoogle Scholar
• Evan, G., Harrington E., Fanidi A., Land H., Amati B., and Bennett M.. 1994. Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos. Trans. R. Soc. London B 345:269–275.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., and Vousden K. H.. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–348.
   PubMed Web of Science ®Google Scholar
• Furstenberger, G., and Senn H. J.. 2002. Insulin-like growth factors and cancer. Lancet Oncol. 3:298–302.
   PubMed Web of Science ®Google Scholar
• Graf, T., von Weizsaecker F., Grieser S., Coll J., Stehelin D., Patschinsky T., Bister K., Bechade C., Calothy G., and Leutz A.. 1986. v-mil induces autocrine growth and enhanced tumorigenicity in v-myc-transformed avian macrophages. Cell 45:357–364.
   PubMedGoogle Scholar
• Greenbaum, L. E., Li W., Cressman D. E., Peng Y., Ciliberto G., Poli V., and Taub R.. 1998. CCAAT enhancer-binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J. Clin. Investig. 102:996–1007.
   PubMed Web of Science ®Google Scholar
• Hawley, R. G., Lieu F. H., Fong A. Z., and Hawley T. S.. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136–138.
   PubMed Web of Science ®Google Scholar
• Hu, H. M., Baer M., Williams S. C., Johnson P. F., and Schwartz R. C.. 1998. Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. J. Immunol. 160:2334–2342.
   PubMed Web of Science ®Google Scholar
• Kagan, B. L., Henke R. T., Cabal-Manzano R., Stoica G. E., Nguyen Q., Wellstein A., and Riegel A. T.. 2003. Complex regulation of the fibroblast growth factor-binding protein in MDA-MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Cancer Res. 63:1696–1705.
   PubMedGoogle Scholar
• Kelley, T. W., Graham M. M., Doseff A. I., Pomerantz R. W., Lau S. M., Ostrowski M. C., Franke T. F., and Marsh C. B.. 1999. Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J. Biol. Chem. 274:26393–26398.
   PubMedGoogle Scholar
• Kowenz-Leutz, E., Twamley G., Ansieau S., and Leutz A.. 1994. Novel mechanism of C/EBP β (NF-M) transcriptional control: activation through derepression. Genes Dev. 8:2781–2791.
   PubMed Web of Science ®Google Scholar
• Kulik, G., Klippel A., and Weber M. J.. 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1595–1606.
   PubMed Web of Science ®Google Scholar
• Lamb, J., Ramaswamy S., Ford H. L., Contreras B., Martinez R. V., Kittrell F. S., Zahnow C. A., Patterson N., Golub T. R., and Ewen M. E.. 2003. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323–334.
   PubMed Web of Science ®Google Scholar
• Lee, A. W., and States D. J.. 2000. Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors. Mol. Cell. Biol. 20:6779–6798.
   PubMedGoogle Scholar
• LeRoith, D., Baserga R., Helman L., and Roberts C. T., Jr. 1995. Insulin-like growth factors and cancer. Ann. Intern. Med. 122:54–59.
   PubMed Web of Science ®Google Scholar
• LeRoith, D., and Roberts C. T., Jr. 2003. The insulin-like growth factor system and cancer. Cancer Lett. 195:127–137.
   PubMed Web of Science ®Google Scholar
• Liu, H., Perlman H., Pagliari L. J., and Pope R. M.. 2001. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-κB, Bad, or caspase activation. J. Exp. Med. 194:113–126.
   PubMed Web of Science ®Google Scholar
• Liu, J. L., Grinberg A., Westphal H., Sauer B., Accili D., Karas M., and LeRoith D.. 1998. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol. Endocrinol. 12:1452–1462.
   PubMedGoogle Scholar
• Liu, J. P., Baker J., Perkins A. S., Robertson E. J., and Efstratiadis A.. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (IGF1r). Cell 75:59–72.
   PubMed Web of Science ®Google Scholar
• McCarthy, T. L., Thomas M. J., Centrella M., and Rotwein P.. 1995. Regulation of insulin-like growth factor I transcription by cyclic adenosine 3′,5′-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: protein kinase A-dependent control without a consensus AMP response element. Endocrinology 136:3901–3908.
   PubMedGoogle Scholar
• McCubrey, J. A., Steelman L. S., Hoyle P. E., Blalock W. L., Weinstein-Oppenheimer C., Franklin R. A., Cherwinski H., Bosch E., and McMahon M.. 1998. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia 12:1903–1929.
   PubMed Web of Science ®Google Scholar
• McCubrey, J. A., Steelman L. S., Moye P. W., Hoyle P. E., Weinstein-Oppenheimer C., Chang F., Pearce M., White M. K., Franklin R., and Blalock W. L.. 2000. Effects of deregulated RAF and MEK1 expression on the cytokine-dependency of hematopoietic cells. Adv. Enzyme Regul. 40:305–337.
   PubMedGoogle Scholar
• Metz, T., Graf T., and Leutz A.. 1991. Activation of cMGF expression is a critical step in avian myeloid leukemogenesis. EMBO J. 10:837–844.
   PubMed Web of Science ®Google Scholar
• Morrione, A., DeAngelis T., and Baserga R.. 1995. Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes. J. Virol. 69:5300–5303.
   PubMed Web of Science ®Google Scholar
• Moschos, S. J., and Mantzoros C. S.. 2002. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63:317–332.
   PubMed Web of Science ®Google Scholar
• Nakajima, T., Kinoshita S., Sasagawa T., Sasaki K., Naruto M., Kishimoto T., and Akira S.. 1993. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 90:2207–2211.
   PubMed Web of Science ®Google Scholar
• Neumann, C., and Sorg C.. 1980. Sequential expression of functions during macrophage differentiation in murine bone marrow liquid cultures. Eur. J. Immunol. 10:834–840.
   PubMedGoogle Scholar
• Okuda, K., Matulonis U., Salgia R., Kanakura Y., Druker B., and Griffin J. D.. 1994. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1. Exp. Hematol. 22:1111–1117.
   PubMed Web of Science ®Google Scholar
• Parrizas, M., Saltiel A. R., and LeRoith D.. 1997. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:154–161.
   PubMed Web of Science ®Google Scholar
• Pelengaris, S., Rudolph B., and Littlewood T.. 2000. Action of Myc in vivo—proliferation and apoptosis. Curr. Opin. Genet. Dev. 10:100–105.
   PubMed Web of Science ®Google Scholar
• Rask, K., Thorn M., Ponten F., Kraaz W., Sundfeldt K., Hedin L., and Enerback S.. 2000. Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBβ) and C/EBζ (CHOP) correlate with invasiveness of human colorectal cancer. Int. J. Cancer 86:337–343.
   PubMedGoogle Scholar
• Resnicoff, M., Coppola D., Sell C., Rubin R., Ferrone S., and Baserga R.. 1994. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54:4848–4850.
   PubMed Web of Science ®Google Scholar
• Resnicoff, M., Sell C., Rubini M., Coppola D., Ambrose D., Baserga R., and Rubin R.. 1994. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res. 54:2218–2222.
   PubMed Web of Science ®Google Scholar
• Robinson, G. W., Johnson P. F., Hennighausen L., and Sterneck E.. 1998. The C/EBPβ transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev. 12:1907–1916.
   PubMedGoogle Scholar
• Seagroves, T. N., Krnacik S., Raught B., Gay J., Burgess-Beusse B., Darlington G. J., and Rosen J. M.. 1998. C/EBPβ, but not C/EBPα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev. 12:1917–1928.
   PubMedGoogle Scholar
• Sell, C., Dumenil G., Deveaud C., Miura M., Coppola D., DeAngelis T., Rubin R., Efstratiadis A., and Baserga R.. 1994. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14:3604–3612.
   PubMed Web of Science ®Google Scholar
• Sell, C., Rubini M., Rubin R., Liu J. P., Efstratiadis A., and Baserga R.. 1993. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 90:11217–11221.
   PubMed Web of Science ®Google Scholar
• Sterneck, E., Blattner C., Graf T., and Leutz A.. 1992. Structure of the chicken myelomonocytic growth factor gene and specific activation of its promoter in avian myelomonocytic cells by protein kinases. Mol. Cell. Biol. 12:1728–1735.
   PubMedGoogle Scholar
• Sterneck, E., Muller C., Katz S., and Leutz A.. 1992. Autocrine growth induced by kinase type oncogenes in myeloid cells requires AP-1 and NF-M, a myeloid specific, C/EBP-like factor. EMBO J. 11:115–126.
   PubMedGoogle Scholar
• Sterneck, E., Tessarollo L., and Johnson P. F.. 1997. An essential role for C/EBPβ in female reproduction. Genes Dev. 11:2153–2162.
   PubMedGoogle Scholar
• Sundfeldt, K., Ivarsson K., Carlsson M., Enerback S., Janson P. O., Brannstrom M., and Hedin L.. 1999. The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPβ during epithelial tumour progression. Br. J. Cancer 79:1240–1248.
   PubMedGoogle Scholar
• Talapatra, S., and Thompson C. B.. 2001. Growth factor signaling in cell survival: implications for cancer treatment. J. Pharmacol. Exp. Ther. 298:873–878.
   PubMedGoogle Scholar
• Tanaka, T., Akira S., Yoshida K., Umemoto M., Yoneda Y., Shirafuji N., Fujiwara H., Suematsu S., Yoshida N., and Kishimoto T.. 1995. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353–361.
   PubMed Web of Science ®Google Scholar
• Thomas, M. J., Umayahara Y., Shu H., Centrella M., Rotwein P., and McCarthy T. L.. 1996. Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts. J. Biol. Chem. 271:21835–21841.
   PubMedGoogle Scholar
• Trojan, J., Blossey B. K., Johnson T. R., Rudin S. D., Tykocinski M., and Ilan J.. 1992. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 89:4874–4878.
   PubMedGoogle Scholar
• Tushinski, R. J., Oliver I. T., Guilbert L. J., Tynan P. W., Warner J. R., and Stanley E. R.. 1982. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28:71–81.
   PubMed Web of Science ®Google Scholar
• Umayahara, Y., Billiard J., Ji C., Centrella M., McCarthy T. L., and Rotwein P.. 1999. CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts. J. Biol. Chem. 274:10609–10617.
   PubMedGoogle Scholar
• Umayahara, Y., Ji C., Centrella M., Rotwein P., and McCarthy T. L.. 1997. CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. J. Biol. Chem. 272:31793–31800.
   PubMedGoogle Scholar
• Valentinis, B., and Baserga R.. 2001. IGF-I receptor signalling in transformation and differentiation. Mol. Pathol. 54:133–137.
   PubMedGoogle Scholar
• Williams, S. C., Cantwell C. A., and Johnson P. F.. 1991. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev. 5:1553–1567.
   PubMed Web of Science ®Google Scholar
• Yee, D. 2001. Are the insulin-like growth factors relevant to cancer? Growth Horm. IGF Res. 11:339–345.
   PubMed Web of Science ®Google Scholar
• Zahnow, C. A. 2002. CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res. 4:113–121.
   PubMedGoogle Scholar
• Zhu, S., Oh H.-S., Shim M., Sterneck E., Johnson P. F., and Smart R. C.. 1999. C/EBPβ modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol. Cell. Biol. 19:7181–7190.
   PubMedGoogle Scholar
• Zhu, S., Yoon K., Sterneck E., Johnson P. F., and Smart R. C.. 2002. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. USA 99:207–212.
   PubMedGoogle Scholar